Author: Norman Billups, Rph, MS, PhD
Publisher:
ISBN: 9781574390704
Category : Medical
Languages : en
Pages : 1048
Get Book Here
Book Description
A dictionary-style listing of more than 22,000 prescription and over-the-counter products. Listings include manufacturer, pronunciation, active ingredients, doseforms, strengths, packaging and uses. Trade names, generics and drug classes are cross-indexed.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Get Book Here
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author: George B. Griffenhagen
Publisher: Amer. Inst. History of Pharmacy
ISBN: 9780931292262
Category : Medical
Languages : en
Pages : 164
Get Book Here
Book Description
Author: James A. Inciardi
Publisher: SAGE
ISBN: 9780761906902
Category : Law
Languages : en
Pages : 196
Get Book Here
Book Description
This completely revised and updated secong edition of the Drug Legalization Debate continues to address, and offer alternatives to, the major issues.
Author: David R. Bewley-Taylor
Publisher: A&C Black
ISBN: 9780826458131
Category : Political Science
Languages : en
Pages : 264
Get Book Here
Book Description
The United States and International Drug Control, 1909-1997 charts the US quest to internationalize the doctrine of drug prohibition. The study reveals the origins, motivation and methodologies as well as the recurring contradictions and inconsistencies present within the US overseas fight against the production, manufacture, trafficking and use of certain psychoactive substances. Drawing on extensive historical materials, David Bewley-Taylor uses the international career of America's first Drug Czar, Harry J. Anslinger, to explore how the US successfully exploited hegemonic superiority in 1945 to influence the philosophy of the multilateral drug control system operated by the United Nations.More than a purely historical study, the book employs an interdisciplinary approach to understanding the development, perpetuation and consequences of a US driven multilateral drug control system. Examining the contemporary UN drug control framework, the author argues that international legislation is largely ineffective.This provocative book is the first study to provide a picture of US involvement in drug control from its inception to the present day. Its wide-ranging scope makes it of interest not only to scholars of diplomatic history, US foreign Policy and international relations, but also to anyone concerned by the universal growth of the illicit drug problem.
Author: Norman F. Billups
Publisher: Facts and Comparisons
ISBN: 9781574390414
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
American Drug Index lists drag names in a time-saving dictionary style. This directory contains more than 22,000 Rx and OTC products, with cross-indexing of trade names, genetics and drug classes. ADI entries also include manufacturer, pronunciation, active ingredients, doseforms, strengths, packaging and uses. Comprehensive index includes a listing of drags which should not be crushed or chewed, drug names that look-alike or sound alike, storage requirements for USP drugs, trademark glossary and normal laboratory values, along with several other tables of hard-to find information.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: Sean C. Sweetman
Publisher:
ISBN: 9780853697046
Category : Medical
Languages : en
Pages : 3335
Get Book Here
Book Description
This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced
Author: Li Di
Publisher: Elsevier
ISBN: 0080557619
Category : Science
Languages : en
Pages : 549
Get Book Here
Book Description
Of the thousands of novel compounds that a drug discovery project team invents and that bind to the therapeutic target, typically only a fraction of these have sufficient ADME/Tox properties to become a drug product. Understanding ADME/Tox is critical for all drug researchers, owing to its increasing importance in advancing high quality candidates to clinical studies and the processes of drug discovery. If the properties are weak, the candidate will have a high risk of failure or be less desirable as a drug product. This book is a tool and resource for scientists engaged in, or preparing for, the selection and optimization process. The authors describe how properties affect in vivo pharmacological activity and impact in vitro assays. Individual drug-like properties are discussed from a practical point of view, such as solubility, permeability and metabolic stability, with regard to fundamental understanding, applications of property data in drug discovery and examples of structural modifications that have achieved improved property performance. The authors also review various methods for the screening (high throughput), diagnosis (medium throughput) and in-depth (low throughput) analysis of drug properties. - Serves as an essential working handbook aimed at scientists and students in medicinal chemistry - Provides practical, step-by-step guidance on property fundamentals, effects, structure-property relationships, and structure modification strategies - Discusses improvements in pharmacokinetics from a practical chemist's standpoint
Author: David Boyum
Publisher: A E I Press
ISBN:
Category : Law
Languages : en
Pages : 158
Get Book Here
Book Description
This book concludes that AmericaOs drug policy should be reoriented in several ways to be more effective.
